TOKYO, Sept. 29, 2026 /PRNewswire/ -- TIER IV, the pioneering force behind open-source software for autonomous driving, has added two new models to its MP camera series optimized for commercial-scale Level 4 autonomy. The C1-120MP and C2-120MP feature a 120-degree wide-angle lens designed specifically for peripheral sensing. Sales commence on September 30, 2026.

First launched in May 2026, the MP camera series is an automotive-grade lineup engineered for advanced autonomous driving systems. The range combines proprietary image optimization with flexible camera control, supporting scalable autonomous deployment across public transit, logistics, construction, and agricultural sectors.

The new 120-degree field-of-view models reduce perimeter blind spots and provide broad situational awareness. Pairing these wide-angle cameras for close-range coverage with narrow-angle cameras for long-range detection offers greater flexibility in system design, minimizing the total camera count without compromising the comprehensive coverage essential for safe autonomous driving. This approach allows for leaner sensor configurations that improve overall system performance by optimizing data processing and reducing power consumption.

Designed for compatibility with Autoware, open-source autonomous driving software, TIER IV's automotive-grade cameras help reduce autonomous driving system development time and costs. TIER IV will continue expanding the MP camera series to accommodate diverse configurations and operational environments, accelerating the deployment and enhancing the safety of Level 4 autonomous driving.

Purchase inquiries

AISAN TECHNOLOGY

https://aisan-mobility.com/en/lineup/c1/

Digiflec

https://digiflec.com/tier-iv/

About TIER IV

TIER IV stands at the forefront of deep tech innovation, pioneering Autoware, open-source software for autonomous driving. With a comprehensive suite of platforms and services built around Autoware, TIER IV provides everything from software development and vehicle procurement to operational support. Through the Autoware ecosystem, TIER IV works with partners worldwide to shape the future of intelligent vehicles with open-source software, aiming to create mobility that is safer, more sustainable, and accessible to all.

Media Contact

[email protected]

Business Inquiries

[email protected]

The word marks and logos of TIER IV are trademarks or registered trademarks of TIER IV, Inc. in Japan and other countries. All other company names, product names, service names, and logos referenced herein are trademarks or registered trademarks of their respective owners.

Autoware is a registered trademark of the Autoware Foundation.

SOURCE TIER IV, Inc.

Share this article

PAAMC HK Lists Ping An AI Select ETF and Ping An Healthcare 50 Select ETF on SEHK

News provided by

Ping An of China Asset Management (Hong Kong) Company Limited

Sep 29, 2026, 21:00 ET

HONG KONG, Sept. 29, 2026 /PRNewswire/ -- Ping An of China Asset Management (Hong Kong) Company Limited ("PAAMC HK" or the "Company" ), the offshore asset management platform of Ping An Insurance (Group) Company of China, Ltd. ("Ping An Group"), is pleased to announce that the Company launches two exchange-traded funds (ETFs) - Ping An AI Select ETF (HKD Counter: 03510/ USD Counter: 41510) and Ping An Healthcare 50 Select ETF (HKD Counter: 03500/ USD Counter: 41500) listed on the Stock Exchange of Hong Kong ("SEHK") today.

Ping An AI Select ETF aims to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive G2 Artificial Intelligence Select Index NTR, a net total return, free float market capitalisation weighted index that provides exposure to AI companies listed in Hong Kong and the United States that meet defined liquidity requirements. Its components span three key segments of the AI value chain: AI infrastructure, AI platforms, and AI applications. Its investment universe is constructed through a multi-dimensional screening process and dynamically updated to reflect global AI technology trends.

The Ping An Healthcare 50 Select ETF (03500 (HKD counter) / 41500 (USD counter)) aims to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive G2 Healthcare 50 Select Index NTR, a net total return, free-float market capitalization-weighted index providing exposure to 50 leading healthcare companies listed in Hong Kong and the United States. Through its constituents, the Index offers access to investment opportunities across the healthcare value chain, from technology R&D to commercialization channels, covering key areas driving pharmaceutical and biotechnology innovation.

"Following our three existing ETFs eligible for Southbound trading under Stock Connect, we are launching two growth-themed ETFs in response to investor demand." said Mr. Albert Wang, Head of Capital Markets and CIO of PAAMC HK, "As technological breakthroughs drive growth across the AI value chain, the Ping An AI Select ETF spans AI infrastructure, platforms and applications, diversifying exposure across technological pathways while capturing innovation-led opportunities. The Ping An Healthcare 50 Select ETF focuses on Chinese pharmaceutical companies spearheading global expansion and U.S. leaders in innovative medicines, offering one-stop access to the sector's long-term global growth potential."

With a focus on product innovation, PAAMC HK offers ETFs designed to provide investors with transparent, consistent and low-cost passive investment tools. By delivering premium allocation solutions during Asian trading hours, PAAMC HK seeks to better serve clients across markets and further enrich Hong Kong's capital market product ecosystem.

Table 1: Key fund facts

END

About Ping An of China Asset Management (Hong Kong) Company Limited

Ping An of China Asset Management (Hong Kong) Company Limited was established in 2006. It is a direct subsidiary of China Ping An Insurance Overseas (Holdings) Limited and a wholly owned subsidiary of Ping An Insurance (Group) Company of China, Ltd. (2318.HK and 601318.SH). It is licensed by the Securities and Futures Commission of Hong Kong ("SFC") to conduct Type 1 (Dealing in Securities), Type 4 (Advising on Securities) and Type 9 (Asset Management) regulated activities. With strong capabilities in investment research and asset management, PAAMC HK is a leading provider of global investment management solutions in equities, fixed income, ETF, structured products and alternative assets. For more information, please visit PAAMC HK's website (asset.pingan.com.hk). (This website has not been reviewed by the SFC).

Disclaimer

This press release is issued by PAAMC HK. This press release is not an offer in relation to any investment. Investments involve risks. Past performance of any products referenced in this press release (the "Product") does not guarantee future returns. Due to market volatility, the Product is subject to market value fluctuation and the risk of loss of principal. Investors should read the Product's offering documents carefully for further details including the risk factors and consider their own financial conditions and the Product's risk situations before making any investment decision. If in doubt, please seek independent financial and professional advice. Please visit PAAMC HK's website for the relevant offering documents. This press release and PAAMC HK's website have not been reviewed by the SFC.

SOURCE Ping An of China Asset Management (Hong Kong) Company Limited

Share this article

Three-year grant from Simply Healthcare Foundation will connect children and families with timely, community-based mental health support

HOLLYWOOD, Fla., September 29, 2026 /PRNewswire/ -- Joe DiMaggio Children's Hospital Foundation has received a $230,000 grant from Simply Healthcare Foundation to expand New Solutions: A Pediatric Mental Health Treatment and Suicide Prevention Program that helps children and families access timely mental health services outside of a traditional hospital setting.

The three-year grant, which began on July 1, will help New Solutions serve 267 individuals while addressing a critical gap between emergency psychiatric treatment and less acute, coordinated community-based care.

Children and adolescents experiencing a mental health crisis are often brought to the emergency department but may not always meet the medical criteria for hospital admission or an involuntary examination under Florida's Baker Act. Through New Solutions, eligible patients can receive the support they need right away, with the option of receiving therapy at home, in school and connected to their daily lives.

"This grant allows us to reach more children and families with the right level of care when they need it most. By providing a direct connection to behavioral health services, we can help families navigate a difficult moment and begin building a path toward long-term well-being," said Tim Curtin, Vice President of Community Services at Memorial Healthcare System.

Patients are referred directly by the hospital's emergency department care coordination team. When a child or adolescent is assessed and does not require hospitalization or a Baker Act but clearly needs behavioral health support, the team provides an immediate and seamless handoff to New Solutions. The goal is to connect the family to services within 24 hours.

New Solutions provides four to six months of support from a full-time therapist and case manager who can offer individualized attention and help families participate in and stay connected to treatment. Services may be provided in the home or at school and can include care coordination, family support and referrals to parenting groups and other community resources.

"New Solutions is supported through philanthropic funding. The program is designed to remove barriers to care, increase participation in treatment and reduce the need for involuntary holds in cases where a less restrictive level of support is appropriate," said Marilyn Camerota, Senior Director of Community Services at Memorial Healthcare System. "We are proud to support a program that brings accessible mental health resources directly to children and families while helping them remain connected to their homes, schools and communities."

The funding will also help New Solutions expand its capacity and raise awareness about the mental health resources available to families.

The announcement comes during Suicide Prevention Month, observed each September to encourage open conversations about mental health and connect individuals with potentially lifesaving resources.

About Memorial Healthcare System

South Florida-based Memorial Healthcare Systemis a national leader in quality care and patient, physician and employee satisfaction. Its commitment to deeper caring, smarter health and community outreach prioritizes a person-centered approach that has delivered safe, positive outcomes for more than 70 years.

Memorial is committed to healing the body, mind and spirit of those in its care. For more information, visit mhs.netand connect on Facebook, X, Instagram, YouTube and LinkedIn.

About Joe DiMaggio Children's Hospital

Joe DiMaggio Children's Hospital is one of the nation's leading pediatric hospitals, offering a comprehensive scope of healthcare services and programs in a caring, compassionate setting designed specifically for children. The level one pediatric trauma center combines advanced technology, the expertise of some of the region's most diverse, board-certified specialists and a patient and family-centered focus to heal the body, mind and spirit.

Part of Memorial Healthcare System, the pediatric hospital in Hollywood, Florida, recently doubled in size, adding four floors, including a comprehensive cardiac care floor, an intraoperative MRI, an inpatient rehabilitation gym, family and staff support areas and the 14th Garth Brooks Teammates for Kids Child Life Zone, among other offerings.

The hospital's nonprofit foundation focuses on philanthropy to positively impact patients, families, and underwrite programs, facilities and equipment that support the pediatric facility's mission.

To learn more, visit jdch.com and connect with @jdchospital on Facebook, X, YouTube and Instagram.

About Simply Healthcare Foundation

Simply Healthcare Foundation is a philanthropic arm of the Elevance Health Foundation. The Foundation works to improve the health of the socially vulnerable through partnerships and programs in our communities with an emphasis on maternal-infant health; behavioral health; and food as medicine. Additionally, the Foundation also responds to disasters when our communities need us the most. To learn more about the Simply Healthcare Foundation, please visit www.elevancehealth.foundation.

SOURCE Memorial Healthcare System

Share this article

Highlights

- First Graphene signs three-year Strategic Partner Agreement with UK-based Vector to expand commercial opportunities for graphene products

- Agreement secured as Vector launches new graphene-enhanced printed heat flux sensors used to measure thermal performance of buildings

- The new 'Peltyr' product represents another commercial application for First Graphene's PureGRAPH® in the construction sector

- Opportunity to market graphene-enhanced heat flux sensors to broader industrial, aerospace, automotive, and HVAC industries

SYDNEY, Sept. 29, 2026 /PRNewswire/ -- First Graphene Limited (ASX: FGR; "First Graphene" or "the Company") (FRA:M11) (OTCQB:FGPHF) has entered into a Strategic Partner Agreement ("Agreement") with UK-based Vector Companies Group Limited ("Vector"), alongside the commercial launch of Vector's Peltyr printed heat flux sensor technology incorporating First Graphene's PureGRAPH®.

The 36-month agreement enables Vector to introduce prospective end-users to First Graphene for its broad range of graphene products. Vector may also purchase products directly from First Graphene under separate purchase orders.

The commercial partnership broadens the existing relationship between the two companies and provides First Graphene with an additional channel to prospective customers through Vector's network across advanced materials, manufacturing and the built environment.

The agreement comes as Vector launched its low-cost printed heat flux sensors, containing First Graphene's PureGRAPH®, into a dedicated product line called Peltyr.

Peltyr is designed to measure the actual rate of heat passing through building fabric such as walls, floors and roofs, enabling users to calculate an in-situ U-value rather than relying solely on modelled assumptions.

A building fabric's U-value is a standard measure of how readily heat passes through a structure, with a lower U-value generally indicating better insulation performance.

This enables building owners, retrofit assessors and housing providers to measure actual thermal performance before and after energy-efficiency upgrades.

Importantly, heat flux sensing is used across building physics, industrial process monitoring, research, aerospace, automotive, HVAC, meteorology and other applications where understanding heat transfer is important.

The global heat flux sensor market is anticipated to reach US$455.8 million by 20341, driven by growing demand from these industries, representing a significant opportunity for First Graphene to expand its commercial presence in this market.

First Graphene Managing Director and CEO, Michael Bell, said:

"Our Strategic Partner Agreement with Vector builds on the productive relationship we've had across advanced materials and gives both companies a framework to identify and progress new commercial opportunities.

The launch of this PureGRAPH®-enhanced heat flux sensor is one such opportunity, representing an important milestone for both Vector and First Graphene and showcasing another example of our products transitioning from development into a commercial reality.

Peltyr demonstrates exactly what we want to achieve with our partners. By using the unique performance characteristics of graphene to solve a real industrial problem, we can develop a product that can be manufactured at scale and commercially adopted by industry.

Buildings account for a significant share of global energy use and measuring how they actually perform is essential as the construction industry moves towards a lower carbon future.

A lower-cost, scalable sensor that can provide real performance data has applications well beyond a single building project, with opportunities in other sectors such as aerospace coming to light.

This heat flux sensor adds another commercially available application to the growing portfolio of products using First Graphene materials, and we look forward to supporting Vector as Peltyr moves through commercial rollout."

SOURCE First Graphene Limited

Share this article

New studio helps game teams scale engineering, art, QA, production, LiveOps, and player support around each title's roadmap.

LOS ANGELES, Sept. 29, 2026 /PRNewswire/ -- Stand8 today announced Evoc8 by Stand8, a game and digital experiences co-development studio built to help development teams extend capacity, access talent, and deliver with flexibility across the production lifecycle.

"Stand8 has always helped organizations use technology to create better experiences for the people they serve. Evoc8 extends that mission into gaming and digital experiences, giving development teams the specialized talent and production support needed to build what comes next," said Quinn Fillmon, Founder and CEO of Stand8.

Evoc8 supports studios from pre-production and development through launch and LiveOps. Its elastic model combines an experienced development bench with international studio partners and Stand8's talent solutions infrastructure. Studios can engage a specialist, discipline pod, production strike team, or integrated team spanning games development and post-release lifecycle.

"Game studios must respond to changing production schedules, launch demands, and market conditions without compromising quality," said Richard Stanley, VP of Digital Experiences and Technology at Stand8. "Evoc8 gives teams flexible access to the capabilities they need, while keeping the studio in control of its IP, product vision, and player relationships."

Evoc8 flexes around milestones, launches, regional requirements, budgets, security needs, and the evolving needs of a live game:

- Make: engineering, art, design, content, tools, infrastructure, data, and release support.

- Support: testing, automation, certification, localization, performance, monitoring, and incident readiness.

- Engage: player support, community operations, moderation, trust and safety, training, and knowledge management.

- Relate: telemetry, analytics, sentiment, retention, experimentation, identity, security, and fraud detection.

- LiveOps: ongoing content, quality, infrastructure, support, community, analytics, security, and commercial operations.

- Evolve: AI, automation, tooling, data, and continuous production improvement.

Evoc8 is grounded in accountability, measurable outcomes, and knowledge continuity. Stand8 provides talent solutions, contracts, legal, finance, compliance, and administration, allowing Evoc8 to focus on digital experiences and operations.

About Evoc8

Evoc8 by Stand8 is a game co-development studio helping teams plan, build, launch, operate, and evolve interactive experiences through flexible production support and capabilities.

To learn more, visit evoc8.io.

About Stand8

Stand8 is a global technology consulting and services leader that helps businesses transform and scale through tailored IT solutions. With a 99% client retention rate and more than 15 years of results, Stand8 delivers secure, compliant, and personalized technology services.

For more information, visit stand8.io.

SOURCE Stand 8

Share this article

Fair Finance Asia Calls for Stronger Equitable Governance and Benefit Sharing in ASEAN's Critical Minerals Trade and Finance

PHNOM PENH, Cambodia, Sept. 29, 2026 /PRNewswire/ -- Association of Southeast Asian Nations (ASEAN) member states are often written out of value chains built on their critical minerals, according to a new report from the Fair Finance Asia (FFA) network and research partner, Profundo.

Among the first to examine the region's critical minerals trade agreements alongside the finance behind them, FFA's report, Extraction to Equity, asks whether deals involving Cambodia, Indonesia, the Philippines, and Thailand advance environmental, social, and governance (ESG) standards.

Drawing on public information up to December 2025, the report found that local-benefits clauses, sustainability standards, and equitable value sharing are consistently missing from agreements and memoranda of understanding (MoUs), leaving source countries shipping raw minerals while processing happens elsewhere. The report also questions how much of this demand may be driven by defense, not renewables, and whose needs are being prioritized.

The report calls on ASEAN member states and financial regulators to incentivize alternatives to extractivism and endorse the UN Principles to Guide Critical Energy Transition Minerals Towards Equity and Justice.

Bernadette Victorio, Program Lead, Fair Finance Asia: "FFA is among the first into this terrain of analysis for one reason: communities living with extractivism are the end beneficiaries of our advocacy, but they cannot demand terms that have not been mapped."

Juliette Laplane, Senior Researcher, Profundo: "Critical minerals agreements must move beyond market access. They need enforceable safeguards including local value addition, fair pricing, and civil society participation."

Sophoan Phean, National Director, Oxfam in Cambodia: "Cambodia is still at an early stage of critical mineral development and must center community rights, environmental protection, and revenue transparency and accountability before large-scale extraction expands."

Victoria Fanggidae, Executive Director, The PRAKARSA: "Banks and investors must make human rights due diligence, community consent, transparent benefit-sharing, and credible decarbonization conditions of finance."

Yuki Tanabe, Program Director, Japan Center for a Sustainable Environment and Society: "Major Japanese banks and companies involved in the mining, refining, processing, and procurement of critical minerals in Southeast Asia must strengthen their ESG standards."

Joel Chester Pagulayan, Climate Justice Portfolio Manager, Oxfam Pilipinas: "ASEAN and national regulators must replace voluntary commitments with mandatory safeguards that advance community rights, free, prior and informed consent (FPIC), and equitable development."

Ponpakin Phruttiwongwanit, Project Coordinator, Fair Finance Thailand: "Unless ASEAN governments and financial regulators close policy gaps, people and ecosystems at the frontline of extraction will keep paying for a transition designed without them."

Access the report: bit.ly/4hraS6Q

Media contacts:

Kyle Cruz

Influencing and Campaigning Manager

Fair Finance Asia

About Fair Finance Asia

FFA is a regional network of Asian civil society organizations working to ensure that financial institutions' funding decisions respect the social and environmental well-being of the communities where they operate. Learn more: fairfinanceasia.org

SOURCE Fair Finance Asia

Share this article

Automotive electronics solutions company builds on smart key supply experience in Taiwan to expand overseas with AI-based around-view and pedal misapplication prevention technologies

SEOUL, South Korea, Sept. 29, 2026 /PRNewswire/ -- Automotive electronics solutions company AP MOBILITY is expanding into the global automotive aftermarket, leveraging its vehicle convenience and safety technologies. Building on the experience it has gained supplying smart key solutions in Taiwan, the company is broadening its overseas business by expanding its product lineup to include AI-based 360-degree around-view and pedal misapplication prevention solutions.

AP MOBILITY develops and supplies a range of mobility solutions based on automotive electronics technology, designed to enhance vehicle safety and convenience. Its flagship products include MAX PRO, an AI-based 360-degree around-view solution; S KEY, a smart key solution that adds a range of convenience features primarily for Hyundai and Kia vehicles; and AB LIGHT, a vehicle safety solution developed to prevent accidents caused by pedal misapplication.

MAX PRO allows drivers to view their surroundings through 360-degree video, helping them more easily identify blind spots and hazards to improve visibility while parking and driving. AP MOBILITY is advancing the technology by combining video technology with vehicle safety to supplement driver visibility.

S KEY is a solution that expands vehicle convenience features by building on the factory smart key systems of Hyundai and Kia vehicles. It is designed to add a variety of functions, including automatic door lock/unlock, lock-while-running, and remote control. Noting that Hyundai and Kia vehicles are also widely distributed overseas, the company is extending the vehicle-specific technology application experience it has accumulated domestically into international markets.

AP MOBILITY has been building its overseas business experience in Taiwan primarily through S KEY LITE. The company has supplied products to local Taiwanese distributors since 2025, shipping approximately 1,100 units to Taiwan between the second half of 2025 and August 2026. Through this experience, the company has confirmed the product's applicability and competitiveness in overseas markets, and plans to further expand overseas supply of S KEY and other automotive electronics products.

Driver safety is another area AP MOBILITY is focusing on for future overseas expansion. Beyond expanding convenience features for existing vehicles, the company is broadening its business into electronics solutions that enhance the safety of both drivers and vehicles.

AB LIGHT reflects this strategy. The product was developed to address risks that can arise from pedal misapplication. It analyzes vehicle CAN data in real time to assess pedal operation and driving conditions, issuing visual and audible warnings when abnormal operation is detected. If dangerous acceleration continues, the system is designed to cut off the accelerator pedal signal. Notably, it is designed to be installed as an aftermarket solution without requiring modification of the vehicle's ECU.

AP MOBILITY notes that pedal misapplication is not a risk confined to any particular age group, but one that can affect any driver. Building on AB LIGHT's ability to be retrofitted onto existing vehicles, the company plans to identify new demand for safety solutions in the automotive aftermarket.

A notable aspect of AP MOBILITY's global strategy is that while each product serves a different function, they share a common thread as aftermarket electronics solutions that complement the functionality and safety of existing vehicles. MAX PRO uses video technology to supplement visibility around the vehicle; S KEY builds on existing smart key systems to expand convenience features; and AB LIGHT uses vehicle CAN data to address risks from pedal misapplication.

In particular, AP MOBILITY plans to leverage its experience developing vehicle-specific technologies for Hyundai and Kia vehicles — which are also widely distributed overseas — as a competitive advantage in its global expansion. The company aims to apply the overseas business experience gained through S KEY's supply in Taiwan to its other product lines, including MAX PRO and AB LIGHT, supplying products tailored to the vehicle environments and market characteristics of each country.

Going forward, AP MOBILITY plans to expand its cooperation with overseas distribution partners, building on the S KEY supply experience it has accumulated in the Taiwanese market. The company will continue to increase the range of applicable vehicle models and supply countries for S KEY, centered on Hyundai and Kia vehicles, drawing on its domestic experience applying technology across different vehicle models to meet the needs of each overseas market.

At the same time, the company is positioning MAX PRO and AB LIGHT as key products for further overseas expansion. MAX PRO will target the market as a video-based vehicle safety and parking solution, while AB LIGHT will do so as a driver safety solution for preventing pedal misapplication, with both products' applicable vehicle models and supply scope to be expanded in stages according to the vehicle environment of each country.

"Building on our product supply experience in the Taiwanese market, we plan to expand cooperation with overseas distribution partners and broaden the supply of our automotive electronics products to a range of countries," an AP MOBILITY representative said. "Over the long term, our goal is to grow into a comprehensive mobility solutions company that supplies a wide range of automotive electronics solutions to the global market — including MAX PRO's video technology, S KEY's vehicle convenience technology, and AB LIGHT's driver safety technology."

SOURCE AP MOBILITY

Share this article

News provided by

California Consortium of Addiction Programs and Professionals

Sep 29, 2026, 18:11 ET

LOS ANGELES, Sept. 29, 2026 /PRNewswire/ -- The California Consortium of Addiction Programs and Professionals (CCAPP) will host the 13th Annual California Addiction Conference (CAC) from October 14-18, 2026, at the Sheraton Universal Hotel in Universal City. This year's event adopts a multi-disciplinary framework by integrating three distinct summits (treatment, recovery capital, and equity) into a single professional gathering.

Interested participants and organizations can access registration and sponsorship details at California Addiction Conference | CCAPP Conferences.

For entities wishing to highlight their offerings, products, or programs, exhibit space applications are currently being accepted for the conference hall. Furthermore, community partners, nonprofits, and businesses are encouraged to participate as conference sponsors. Through several tiers of sponsorship, these organizations have the opportunity to enhance their brand recognition, interact personally with behavioral health and addiction specialists, and show their dedication to improving recovery, treatment, and workforce initiatives throughout California.

Integrated Programming Tracks

- California Addiction Conference (CAC): Provides evidence-based workshops, continuing education units (CEUs), and clinical updates for frontline counselors and treatment administrators.

- National Recovery Capital Conference (NRCC): Focuses on the infrastructure of long-term recovery, including housing, employment, and community-based social connections.

- Diversity, Equity & Inclusion Conference (DEIC): Tackles systemic barriers to care and promotes culturally responsive treatment practices within the workforce.

Assemblymember Rick Chavez Zbur is scheduled to deliver a keynote address on Friday, October 16, 2026. His presentation will analyze current public policy and behavioral health initiatives impacting California's addiction treatment network. By bridging the gap between legislative intent and clinical practice, the conference aims to provide attendees with actionable strategies to improve patient outcomes.

"Bringing together hundreds of professionals, students, and experts for five days of collaboration at the Sheraton Universal Hotel allows us to address some of the most urgent challenges facing behavioral health today," said CCAPP CEO Pete Nielsen. "By connecting treatment providers, recovery advocates, policymakers, researchers, and emerging professionals in one place, this conference helps strengthen the workforce, advance recovery-focused solutions, and accelerate the exchange of ideas that can improve outcomes in communities across California and beyond."

About CCAPP: The California Consortium of Addiction Programs and Professionals (CCAPP) is one of California's recognized certifying bodies for Substance Use Disorder (SUD) counselors. Through credentialing, continuing education, scholarships, workforce development, advocacy, membership, and quality oversight, CCAPP supports behavioral health professionals and the organizations that serve millions of Californians each year.

Visit CCAPP: California Consortium of Addiction Programs and Professionals

CONTACT: [email protected]

SOURCE California Consortium of Addiction Programs and Professionals

Share this article

- Study met its primary endpoint: timing of sleep onset shifted 37.1 minutes earlier versus placebo (p=0.022)

- 60% of HETLIOZ® treated participants shifted sleep at least 30 minutes earlier, compared to 15% of the placebo arm

WASHINGTON, Sept. 29, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced positive topline results from its pivotal Phase III study of HETLIOZ® (tasimelteon) 20 mg in adults with Delayed Sleep-Wake Phase Disorder (DSWPD). Vanda intends to discuss these data with the U.S. Food and Drug Administration (FDA) and to submit a supplemental New Drug Application (sNDA) seeking approval of HETLIOZ® for DSWPD. If approved, HETLIOZ® would be the first FDA-approved medicine indicated for this condition.

HETLIOZ® is already an approved circadian regulator. The FDA first approved it in 2014 to treat Non-24-Hour Sleep-Wake Disorder in adults, and in 2020 to treat nighttime sleep disturbances in people with Smith-Magenis Syndrome. The DSWPD program would extend that same medicine, at the same 20 mg dose, to a third circadian sleep-wake disorder.

Delayed Sleep-Wake Phase Disorder (DSWPD)

DSWPD is a body-clock disorder, and not simply being a "night owl." In a typical night owl, late bedtimes are a preference. In DSWPD, the internal clock is stably set too late. People with the disorder often cannot fall asleep until the early morning hours even when they get into bed at a conventional time, then cannot wake for work, school, or family life the next morning — even if they allow a full night in bed.1 Estimated prevalence in adults is 0.2% to 1.5%, or roughly 0.5 to 4.1 million adults in the United States.2,3 The condition is often comorbid with other common psychiatric disorders. 4,5

Clinical Study results

VP-VEC-162-3502 (NCT04652882) was a multicenter, double-blind, randomized, placebo-controlled Phase III study.6 Adults 18 to 75 years of age with a confirmed clinical diagnosis of DSWPD received once-daily oral tasimelteon 20 mg or matching placebo for 28 days. The study evaluated over 260 individuals and enrolled a total of 43 patients with DSWPD across 26 clinical sites in the US and Europe for a period of over 5 years.

The study met its primary endpoint. HETLIOZ® 20 mg (n=20) shifted the time of sleep onset 42.5 minutes earlier, compared with a 5.4-minute shift on placebo (n=20) — a 37.1-minute difference from placebo (p=0.022). The primary endpoint was the start time of the sleep episode, measured by sleep diary.

In an exploratory responder analysis, 60% of tasimelteon-treated participants (12/20) advanced their sleep timing onset by at least 30 minutes, compared with 15% on placebo (3/20) (p=0.008).

Safety over the 28-day controlled period was consistent with the established HETLIOZ® label. No new safety signals were identified.

"People with DSWPD often remain undiagnosed and undertreated especially because of the absence of a proven approved treatment," said Mihael H. Polymeropoulos, M.D., President, CEO and Chairman of the Board. "This study extends our knowledge of the clinical properties of HETLIOZ® as a versatile circadian regulator. We look forward to discussing these data with the FDA and pursuing a new indication for HETLIOZ® as the first ever approved treatment for DSWPD."

Vanda plans to file an sNDA for HETLIOZ® in DSWPD. The application is expected to include this Phase III study together with Vanda's prior studies in related disorders and more than a decade of use in two approved circadian indications.

About HETLIOZ® (tasimelteon)

HETLIOZ® is a dual melatonin MT1 and MT2 receptor agonist. It is FDA-approved for the treatment of Non-24-Hour Sleep-Wake Disorder in adults (approved 2014) and for the treatment of nighttime sleep disturbances in Smith-Magenis Syndrome (approved 2020; capsules in patients 16 years and older and HETLIOZ LQ® oral suspension in patients 3 to 15 years of age).7 It is not currently approved for DSWPD.

About Vanda Pharmaceuticals Inc.

Vanda is a leading biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on HETLIOZ®, see the full Prescribing Information.

References

- American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed., Text Revision (ICSD-3-TR). Darien, IL: AASM; 2023.

- Nesbitt AD. Delayed sleep-wake phase disorder. J Thorac Dis. 2018;10(Suppl 1):S103-S111.

- US Census Bureau, Vintage 2025 population estimates, age 18 and older.

- Takaesu Y, Inoue Y, Murakoshi A, et al. Prevalence of circadian rhythm sleep-wake disorders and associated factors in euthymic patients with bipolar disorder. PLoS One. 2016;11(7):e0159578. doi:10.1371/journal.pone.0159578 (PLOS One, PubMed 27442503)

- Reis C, Paiva T. Sleep Sci. 2019;12(3):203-213.

- ClinicalTrials.gov NCT04652882.

- HETLIOZ® Prescribing Information

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Various statements in this press release, including but not limited to statements regarding Vanda's plans to submit an sNDA for HETLIOZ® in DSWPD and the likelihood of receiving regulatory approval of HETLIOZ® for the treatment of DSWPD are "forward-looking statements" under the securities laws. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements are based upon current expectations and assumptions that involve risks, changes in circumstances and uncertainties. Important factors that could cause actual results to differ materially from those reflected in Vanda's forward-looking statements include, among others, uncertainties relating to the timing and outcome of the regulatory approval process for HETLIOZ® for the treatment of DSWPD. Therefore, no assurance can be given that the results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Forward-looking statements in this press release should be evaluated together with the various risks and uncertainties that affect Vanda's business and market, particularly those identified in the "Cautionary Note Regarding Forward-Looking Statements", "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's most recent Annual Report on Form 10-K, as updated by Vanda's subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov.

All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this press release is provided only as of the date of this press release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Corporate Contact:

Kevin Moran

Senior Vice President, Chief Financial Officer and Treasurer

Vanda Pharmaceuticals Inc.

202-734-3400

[email protected] 

Jim Golden / Jack Kelleher / Dan Moore

Collected Strategies

[email protected] 

Follow us on X @vandapharma

SOURCE Vanda Pharmaceuticals Inc.

Share this article

In the news release, AeroPress Unveils New Walnut Collection Ahead of National Coffee Day, issued 28-Sep-2026 by AeroPress over PR Newswire, we are advised by the company that hyperlinks within the text have been updated. The complete, corrected release follows:

AeroPress Unveils New Walnut Collection Ahead of National Coffee Day

Crafted with solid clear-grade walnut, the global brand's newest coffee maker and precision manual grinder deliver an elevated coffee station, from grind to brew

PALO ALTO, Calif., Sept. 28, 2026 /PRNewswire/ -- Great coffee deserves more than an ordinary setup. Just in time for National Coffee Day, AeroPress, Inc., maker of the iconic 3-in-1 brew method with 75,000+ five-star reviews in over 70 countries, is giving coffee lovers an elevated upgrade with the launch of its new Walnut collection featuring two new products, made with solid, clear-grade walnut. The new AeroPress Premium Walnut Brewer and AeroPress Walnut Manual Grinder bring a rich, natural finish to its lineup of high-performance coffee makers and accessories.

AeroPress Premium Walnut builds on the success of the brand's existing award-winning Premium Collection, which has become a fan favorite and routinely sells out as new inventory becomes available. Like its predecessors, the latest addition is built from hand-crafted, double-wall borosilicate glass, 304 stainless steel and aluminum, features laser-etched markings for accurate measurement and has been reimagined with a solid clear-grade walnut plunger and flange. Even the scoop and stirrer are crafted from solid walnut.

Second in the Walnut Collection is the new Walnut Manual Grinder, which packs professional-grade grinding performance into a beautifully crafted, compact design, featuring a solid, clear-grade walnut handle and catch casing. Thoughtfully engineered with Italian-made, titanium-coated 38mm conical burrs, 60+ defined grind settings, a 25-gram capacity, a lifetime burr warranty, and a patent-pending Easy-Grind system and dual bearings, the grinder features a removable magnetic handle that stores inside the AeroPress—a first-of-its-kind design that creates a more compact and integrated brewing experience.

At a time when consumers continue to embrace organic textures and nature-inspired design in the home, the collection brings the beauty of solid wood to the everyday coffee ritual, using the highest walnut grade possible, incorporated directly into the product's construction rather than a simple decorative accent. Beneath its elevated exterior, the brewer features AeroPress's patented 3-in-1 brewing technology, delivering a rich, smooth, exceptionally clean-tasting cup that combines the best qualities of espresso, pour-over and French press coffee in under two minutes. The new grinder delivers the precision, performance, portability and ease of use AeroPress fans have come to expect.

"The kitchen has become a place where function and personal style come together, and we believe your coffee setup should be a part of that," said AeroPress CEO Gerard Meyer. "Instead of something you tuck away in the cabinet, the AeroPress Premium Walnut and Walnut Manual Grinder are designed to be proudly displayed on one's countertop, to make a statement and serve as a centerpiece for coffee lovers."

"Wood felt like a natural way to bring warmth and more character to a product our fans already love, while staying true to our roots," added David Cole, CMO of AeroPress. "With the holiday gifting season around the corner, the new Walnut Collection allows us to offer an even broader range of options for coffee enthusiasts. Whether someone is drawn to the natural materials and craftsmanship of the Walnut Collection or prefers our sleek glass & metal Premium Silver, Black or White colorways and our all-metal Manual Grinder, there's a perfect gift for every brewing style and aesthetic."

The new AeroPress Premium Walnut Brewer and new AeroPress Walnut Manual Grinder each retail for $249.95 USD ($319.95 CAD) and are available beginning today for purchase on AeroPress.com and Williams-Sonoma.com.

ABOUT AEROPRESS 

AeroPress was invented by engineer Alan Adler, who set out to create a better way to brew a single cup of coffee — smoother, more flavorful and faster. His breakthrough, air pressure, sped up extraction and reduced bitterness, unlocking the full flavor of the coffee bean in every cup. AeroPress was invented by engineer Alan Adler, who set out to create a better way to brew a single cup of coffee — smoother, more flavorful and faster. His breakthrough, air pressure, sped up extraction and reduced bitterness, unlocking the full flavor of the coffee bean in every cup.

Part French Press, part Pour-Over and part Espresso, AeroPress uses patented 3-in-1 flavor technology that combines immersion, air pressure and micro-filtration. The result: a clean, full-bodied cup with less bitterness and no grit, brewed in under 2 minutes.

Unlike traditional brewing methods, AeroPress offers complete control over every variable — enabling recipes from cold brew and iced coffee to rich espresso-style drinks like cappuccinos and lattes. With its travel-friendly design and fast brewing process, AeroPress has become a favorite of baristas, world champions and everyday coffee lovers. More than 75,000 five-star reviews and the fan-fueled World AeroPress Championship — the largest filtered coffee competition in the world, spanning 70+ countries — underscore its global impact.

To learn more, visit AeroPress.com or follow us on Instagram, Facebook, TikTok, YouTube, Pinterest and LinkedIn.

SOURCE AeroPress

Share this article